For the Inventor, By the Inventor

Enter assignee name

Gainesville, VA, United States of America

Synthon IP Inc.

USPTO Granted Patents = 16

% Expired Patents = 87.5

Forward Citations = 63

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Theodorus H A Peters (5 out of 17 patents)

Lambertus Thijs (4 out of 10 patents)

Rolf Keltjens (3 out of 9 patents)

4. Jie Zhu (3 out of 10 patents)

5. Jacobus Maria Lemmens (3 out of 21 patents)

6. Franciscus B G Benneker (3 out of 9 patents)

7. Montserrat Gallego Luengo (2 out of 3 patents)

8. Joan Cucala Escoi (2 out of 2 patents)

9. Frantisek Picha (2 out of 18 patents)

10. Gerrit J B Ettema (1 out of 6 patents)

11. Jiri Bartl (1 out of 8 patents)

12. Arjanne Overeem (1 out of 8 patents)

13. Reinerus G Gieling (1 out of 2 patents)

14. Inocencia Margallo Lana (1 out of 2 patents)

15. Jaroslav Pis (1 out of 3 patents)

16 patents: Sort by Forward Citations

1. 7776358 - Extended release venlafaxine besylate tablets (2010-08-17),

2. 7541470 - Processes for making pioglitazone and compounds of the processes (2009-06-02),

3. 7501517 - Process for making montelukast and intermediates therefor (2009-03-10),

4. 7491848 - Process for making desvenlafaxine (2009-02-17),

5. 7405298 - Process for making risperidone and intermediates therefor (2008-07-29),

6. 7365086 - Pramipexole acid addition salts (2008-04-29),

7. 7364755 - Modified calcium phosphate excipient (2008-04-29),

8. 7335380 - Amlodipine free base (2008-02-26),

9. 7329747 - Synthesis of olanzapine and intermediates thereof (2008-02-12),

10. 7230016 - Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same (2007-06-12),

11. 7217822 - Process for making cabergoline (2007-05-15),

12. 7199247 - Amide derivative of amlodipine (2007-04-03),

13. 7186854 - Process for making bicalutamide and intermediates thereof (2007-03-06),

14. 7115638 - Amide derivative of amlodipine (2006-10-03),

15. 7041834 - Process for making ondansetron and intermediates thereof (2006-05-09),

Company Overview

Synthon IP Inc. is a technology-driven organization based in Gainesville, Virginia, specializing in the development and commercialization of innovative pharmaceutical solutions. The company focuses on advanced drug delivery systems and formulation technologies, aiming to enhance therapeutic efficacy and patient compliance. With a commitment to research and development, Synthon IP Inc. collaborates with various stakeholders in the healthcare sector to bring cutting-edge products to market, addressing unmet medical needs and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#2 in Gainesville, VA

#332 in Virginia

#19,935 in US

#37,868 in the World

Gainesville, VA, United States of America

Synthon IP Inc.

Forward Citations = 63

26 inventors:

Theodorus H A Peters (5 out of 17 patents)

Lambertus Thijs (4 out of 10 patents)

Rolf Keltjens (3 out of 9 patents)

4. Jie Zhu (3 out of 10 patents)

5. Jacobus Maria Lemmens (3 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synthon IP Inc.. Retrieved from https://idiyas.com/company/synthon-ip

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…